Top Markets
#1 Official Trump Official Trump +51.60%
#2 Movement Movement +32.33%
#3 Mubarak Mubarak +26.27%
#4 Pearl Pearl +24.49%
#5 Zama Zama +24.44%
#6 Melania Meme Melania Meme +22.38%
#7 EXOD EXOD +18.93%
#8 Wrapped POL Wrapped POL +18.74%
#9 POL (ex-MATIC) POL (ex-MATIC) +18.66%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +16.92%
Coin of the day
Official Trump Official Trump
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Citius Oncology, Inc. Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
Clasificación en acciones #23802
Citius Oncology, Inc. concentrates on advancing innovative, targeted... Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
Precio por acción
$0.7426
Última sincronización: 2026-08-21
Capitalización bursátil
$69.05M
Cambio (1 día)
-2.17%
Cambio (1 año)
-57.57%
País
US
Comercio Citius Oncology, Inc. (CTOR)

Categoría

Healthcare
Historial del precio de la acción de Citius Oncology, Inc. (CTOR)
Precio más alto de cierre: $0.77 el 2026-08-01

Precio más bajo de cierre: $11.37 el 2024-07-01
Historial del precio de la acción de Citius Oncology, Inc. desde 2024 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -4.49%
2025 2.60%
2024 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.26K 76.64%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $270.77 51.02%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $265.40 26.02%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $493.69 44.66%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $152.42 74.45%
US